Erschienen in:
13.07.2016 | Editorial
Synthetic mesh in pelvic reconstructive surgery: an ongoing saga
verfasst von:
Peter L. Dwyer, Paul Riss
Erschienen in:
International Urogynecology Journal
|
Ausgabe 9/2016
Einloggen, um Zugang zu erhalten
Excerpt
Controversy surrounding the use of polypropylene mesh to treat stress urinary incontinence (SUI) and pelvic organ prolapse (POP) continues and has entered a new phase, with large healthcare companies withdrawing from the area of female pelvic floor surgery either partially (Perigee, Johnson & Johnson) or completely (Astora Womens Health; formerly American Medical Systems). This has occurred because of adverse publicity and cost of medical ligation mainly in the USA. We have covered this issue previously in an editorial and debate [
1] but feel further discussion is warranted, having reached this new stage. …